Bottle Label 800mg (43353 190)
This is a listing for 270 tablets of Gabapentin, each containing 800mg.*
Gabapentin
Product Images NDC 43353-190
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 43353-190). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Aphena Pharma Solutions (TN)
Not available.*
Gabapentin-fig01 (Gabapentin Fig01)
This is a graph depicting the weekly mean pain scores for Study 1. The graph shows the results of a 4-week dose titration period, followed by a 4-week fixed dose period. The placebo is represented by an "O" symbol and gabapentin, 3600 mg/day, is represented by an "&" symbol. The graph shows that gabapentin significantly reduced pain compared to the placebo.*
Gabapentin-fig02 (Gabapentin Fig02)
The graph shows the results of a study (Study 2) on the mean pain score over a 3-week dose titration period and a 4-week fixed dose period. The study used a placebo and two different doses of Gabapentin (1800 mg/day and 2400 mg/day). The graph shows a significant decrease in pain scores for both Gabapentin doses compared to placebo. The text also includes a copyright symbol and some characters that are not clear, followed by a footnote indicating that p<0.01.*
Gabapentin-fig03 (Gabapentin Fig03)
The text provides the results of controlled studies conducted to evaluate the effectiveness of PBO and GBP for treating PHN. The results are presented in Figure 3, which displays the percentage of patients who responded positively to treatment (defined as those with a reduction in pain score of >50%) at the study endpoint. The data from two separate studies are presented. There are also symbols indicating the level of statistical significance (p values) for the results.*
Gabapentin-fig04 (Gabapentin Fig04)
The text provides data for responder rates in patients receiving Gabapentin as an adjunctive therapy in partial seizures. The data is presented as a difference from placebo by dose and study. Daily doses are listed as 600mg, 900mg, 1200mg, and 1800mg.*
Gabapentin-structure (Gabapentin Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
